220 related articles for article (PubMed ID: 18299447)
1. Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias.
Kim WJ; Okimoto RA; Purton LE; Goodwin M; Haserlat SM; Dayyani F; Sweetser DA; McClatchey AI; Bernard OA; Look AT; Bell DW; Scadden DT; Haber DA
Blood; 2008 May; 111(9):4716-22. PubMed ID: 18299447
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells.
Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M
Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074
[TBL] [Abstract][Full Text] [Related]
3. Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development.
Stoffel W; Jenke B; Blöck B; Zumbansen M; Koebke J
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4554-9. PubMed ID: 15764706
[TBL] [Abstract][Full Text] [Related]
4. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
5. Effect of procysteine on aging-associated changes in hepatic GSH and SMase: evidence for transcriptional regulation of smpd3.
Deevska G; Sunkara M; Karakashian C; Peppers B; Morris AJ; Nikolova-Karakashian MN
J Lipid Res; 2014 Oct; 55(10):2041-52. PubMed ID: 25047167
[TBL] [Abstract][Full Text] [Related]
6. Neutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition.
Stoffel W; Hammels I; Jenke B; Binczek E; Schmidt-Soltau I; Brodesser S; Schauss A; Etich J; Heilig J; Zaucke F
Cell Death Dis; 2016 Nov; 7(11):e2488. PubMed ID: 27882938
[TBL] [Abstract][Full Text] [Related]
7. Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.
Yabu T; Imamura S; Yamashita M; Okazaki T
J Biol Chem; 2008 Oct; 283(44):29971-82. PubMed ID: 18678863
[TBL] [Abstract][Full Text] [Related]
8. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
9. Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure.
Zager RA; Conrad S; Lochhead K; Sweeney EA; Igarashi Y; Burkhart KM
Kidney Int; 1998 Mar; 53(3):573-82. PubMed ID: 9507201
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes.
Magnoni C; Euclidi E; Benassi L; Bertazzoni G; Cossarizza A; Seidenari S; Giannetti A
Toxicol In Vitro; 2002 Aug; 16(4):349-55. PubMed ID: 12110272
[TBL] [Abstract][Full Text] [Related]
11. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
12. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.
Shakor AB; Atia M; Ismail IA; Alshehri A; El-Refaey H; Kwiatkowska K; Sobota A
Biochim Biophys Acta; 2014 Dec; 1841(12):1672-82. PubMed ID: 25240837
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase.
Taguchi Y; Kondo T; Watanabe M; Miyaji M; Umehara H; Kozutsumi Y; Okazaki T
Blood; 2004 Nov; 104(10):3285-93. PubMed ID: 15271800
[TBL] [Abstract][Full Text] [Related]
14. Targeting acid sphingomyelinase reduces cardiac ceramide accumulation in the post-ischemic heart.
Klevstig M; Ståhlman M; Lundqvist A; Scharin Täng M; Fogelstrand P; Adiels M; Andersson L; Kolesnick R; Jeppsson A; Borén J; Levin MC
J Mol Cell Cardiol; 2016 Apr; 93():69-72. PubMed ID: 26930027
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of tumor necrosis factor alpha on the sphingomyelin-ceramide pathway in two myeloid leukemia cell lines: role of transverse sphingomyelin distribution in the plasma membrane.
Bettaieb A; Record M; Côme MG; Bras AC; Chap H; Laurent G; Jaffrézou JP
Blood; 1996 Aug; 88(4):1465-72. PubMed ID: 8695867
[TBL] [Abstract][Full Text] [Related]
16. Neutral Sphingomyelinases in Cancer: Friend or Foe?
Clarke CJ
Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
[TBL] [Abstract][Full Text] [Related]
17. Acid sphingomyelinase-derived ceramide is not required for inflammatory cytokine signalling in murine macrophages.
Manthey CL; Schuchman EH
Cytokine; 1998 Sep; 10(9):654-61. PubMed ID: 9770326
[TBL] [Abstract][Full Text] [Related]
18. Neutral sphingomyelinase: past, present and future.
Chatterjee S
Chem Phys Lipids; 1999 Nov; 102(1-2):79-96. PubMed ID: 11001563
[TBL] [Abstract][Full Text] [Related]
19. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling.
Wiegmann K; Schütze S; Machleidt T; Witte D; Krönke M
Cell; 1994 Sep; 78(6):1005-15. PubMed ID: 7923351
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells.
Yang Z; Costanzo M; Golde DW; Kolesnick RN
J Biol Chem; 1993 Sep; 268(27):20520-3. PubMed ID: 8376408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
